<?xml version="1.0" encoding="ISO-8859-1"?>










<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:html="http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<channel>
<atom:link href="http://test.theheart.org/rssfeed.do" rel="self" type="application/rss+xml" />
<title>theHeart.org</title>
<link>http://test.theheart.org/</link>
<description></description>
<image>
 <url>http://www.theheart.org/documents/sitestructure/resources/images/maintho_logo_rss.png</url>
 <title>theHeart.org</title>
 <link>http://test.theheart.org/</link>
</image>




	<item>
	<link>http://test.theheart.org/article/1027357.do</link>
	<title>Sen Grassley questions top medical schools about ghostwriting</title>
	<description>
	
	   <![CDATA[ As part of his mission to see more financial transparency in medicine, Sen Grassley has asked eight top US medical schools about their policies on ghostwriting.  ]]>
	
	</description>
	<pubDate>
	Fri, 20 Nov 2009 13:15:28 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1027357.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1027255.do</link>
	<title>Stroke incidence related to PCI steady over 15 years </title>
	<description>
	
	   <![CDATA[ Mayo Clinic researchers report that their stroke rate related to PCI has stayed steady for the last 15 years, something they interpret as good news, given that substantially older, sicker patients with more complex anatomy are now undergoing PCI.  ]]>
	
	</description>
	<pubDate>
	Fri, 20 Nov 2009 13:00:13 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1027255.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1026921.do</link>
	<title>ALLHAT investigators report 10-year follow-up and stand by diuretics as first step antihypertensive treatment </title>
	<description>
	
	   <![CDATA[ New 10-year mortality and morbidity data confirm the original trial conclusions, they say, that while amlodipine and lisinopril are not superior to chlorthalidone on any outcome, chlorthalidone is superior to these agents on one or more secondary end points. Full agreement with this conclusion in the community, though, is still hard to come by.  ]]>
	
	</description>
	<pubDate>
	Thu, 19 Nov 2009 14:00:01 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1026921.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1026791.do</link>
	<title>Oral anticoagulants REDEEMed? Daily dabigatran &quot;safe&quot; with dual antiplatelets after MI </title>
	<description>
	
	   <![CDATA[ A dose-finding study saw what were characterized as low bleeding rates associated with triple-drug antithrombotic therapy that included the oral anticoagulant dabigatran in patients with a recent ACS event and other cardiovascular risk factors.   ]]>
	
	</description>
	<pubDate>
	Thu, 19 Nov 2009 11:00:11 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1026791.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1026701.do</link>
	<title>EFFECT: Public reporting of hospital performance improves quality of care? </title>
	<description>
	
	   <![CDATA[ Publicly released report cards based on hospital performance did not result in a measurably greater systemwide improvement in two composite AMI or CHF process-of-care indicators in a Canadian study. But they did appear to stimulate some important changes in delivery of care that could have led to some better outcomes. ]]>
	
	</description>
	<pubDate>
	Thu, 19 Nov 2009 10:00:55 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1026701.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1024841.do</link>
	<title>Kenneth Baughman killed while jogging at AHA</title>
	<description>
	
	   <![CDATA[ <b><i>UPDDATED</i></b> //<i> </i>Dr Kenneth Baughman, a cardiologist at Brigham and Women's Hospital, died Monday morning in Orlando, FL, when he was struck by a car while out for a morning run. ]]>
	
	</description>
	<pubDate>
	Thu, 19 Nov 2009 08:30:46 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1024841.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1026477.do</link>
	<title>BARI 2D cost-effectiveness analysis favors medication over PCI for less severe CVD in diabetic patients</title>
	<description>
	
	   <![CDATA[ New data from the BARI 2D trial comparing medical therapy vs revascularization in diabetics shows higher up-front costs of revascularization are only partially offset by long-term savings. ]]>
	
	</description>
	<pubDate>
	Wed, 18 Nov 2009 15:45:07 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1026477.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1026431.do</link>
	<title>Ticagrelor effects unraveled in new phase 2 trials </title>
	<description>
	
	   <![CDATA[ New and unique phase 2 data add to the growing body of evidence explaining the pharmacologic effects of the new antiplatelet agent ticagrelor. ]]>
	
	</description>
	<pubDate>
	Wed, 18 Nov 2009 15:00:52 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1026431.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1026349.do</link>
	<title>CT-STAT: CT angiography rules out CAD faster and cheaper than standard care</title>
	<description>
	
	   <![CDATA[ The use of coronary CT angiography in the emergency room can successfully triage at-risk chest-pain patients and can do so faster and less expensively than standard diagnostic testing<b>.</b> ]]>
	
	</description>
	<pubDate>
	Wed, 18 Nov 2009 13:45:38 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1026349.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1025731.do</link>
	<title>Baseline function data from STICH no help in pinpointing patients who benefit from SVR</title>
	<description>
	
	   <![CDATA[ Measures of left ventricular dysfunction or wall motion identified by different imaging modalities at baseline offer no clues as to whether a subset of patients treated with surgical ventricular reconstruction might benefit from the procedure.  ]]>
	
	</description>
	<pubDate>
	Wed, 18 Nov 2009 10:45:20 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1025731.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1025547.do</link>
	<title>ACC/AHA focused update of guidelines for STEMI, PCI </title>
	<description>
	
	   <![CDATA[ The latest evidence for the treatment of STEMI and PCI has been incorporated into a fast-track update of US guidelines. But questions remain about the quality of some of the evidence informing the guidelines and about the composition of the writing committees.  ]]>
	
	</description>
	<pubDate>
	Wed, 18 Nov 2009 09:00:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1025547.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1025583.do</link>
	<title>JCHF: Are low doses of carvedilol effective in heart failure? </title>
	<description>
	
	   <![CDATA[ Doses of carvedilol as low as 2.5 mg daily may be effective in Japanese patients with heart failure, according to this study. But experts said the trial was far too small to draw any meaningful conclusions.  ]]>
	
	</description>
	<pubDate>
	Wed, 18 Nov 2009 09:00:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1025583.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1025233.do</link>
	<title>Niacin not beneficial in patients at goal with statins: NIA Plaque</title>
	<description>
	
	   <![CDATA[ The addition of niacin to statin therapy in secondary-prevention patients resulted in a significant improvement in lipids but failed to significantly alter atherosclerotic disease progression as measured by MRI. Researchers say it's a win for treating patients to target and suggest this trumps raising HDL. ]]>
	
	</description>
	<pubDate>
	Wed, 18 Nov 2009 09:00:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1025233.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1025211.do</link>
	<title>CDC data show LDL screening rate remains stagnant; many who could benefit go without lipid-lowering drugs</title>
	<description>
	
	   <![CDATA[ Editorialists discuss simplifying LD-management guidelines in light of a CDC study in which two-thirds of subjects who are at high risk for developing coronary disease within 10 years and eligible for lipid-lowering drugs were not on the medication. ]]>
	
	</description>
	<pubDate>
	Tue, 17 Nov 2009 17:45:53 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1025211.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1024935.do</link>
	<title>RE-LY: Post hoc analysis confirms benefit of dabigatran relative to warfarin at all INR levels</title>
	<description>
	
	   <![CDATA[ A new analysis confirms that regardless of INR control achieved across participating centers, dabigatran remained noninferior at the lower dose and superior at the higher dose to warfarin for prevention of stroke and systemic embolism. ]]>
	
	</description>
	<pubDate>
	Tue, 17 Nov 2009 16:30:06 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1024935.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1025121.do</link>
	<title>Cardiologists shocked by new FDA alert on clopidogrel-PPI interaction </title>
	<description>
	
	   <![CDATA[ The FDA has issued a new warning on an interaction between clopidogrel and the PPI omeprazole and other drugs that inhibit the CYP2C19 enzyme, just weeks after the only randomized trial on this issue reported no such interaction.  ]]>
	
	</description>
	<pubDate>
	Tue, 17 Nov 2009 15:45:02 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1025121.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1022557.do</link>
	<title>Statins do not eliminate risk of low HDL-cholesterol levels</title>
	<description>
	
	   <![CDATA[ Researchers say a new study shows that statins don't alter the risks associated with low HDL-cholesterol levels and that raising HDL cholesterol 10 mg/dL could prevent an additional eight MIs per 1000 patient-years. ]]>
	
	</description>
	<pubDate>
	Tue, 17 Nov 2009 14:45:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1022557.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1024497.do</link>
	<title>Anthracycline cardiotoxicity appears limited in breast cancer in the short term</title>
	<description>
	
	   <![CDATA[ No significant incidence of short-term cardiac toxicity was observed in breast-cancer patients on dose-dense anthracycline regimens, but longer-term follow-up is needed.  ]]>
	
	</description>
	<pubDate>
	Tue, 17 Nov 2009 11:15:44 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1024497.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1024651.do</link>
	<title>POPE: No benefit of diclofenac on pericardial effusion </title>
	<description>
	
	   <![CDATA[ Mean pericardial effusion grade postcardiac surgery was not reduced with 14 days of treatment with the NSAID. ]]>
	
	</description>
	<pubDate>
	Tue, 17 Nov 2009 10:00:33 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1024651.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1024575.do</link>
	<title>CASCADE: No significant benefit of clopidogrel in reducing graft disease after CABG </title>
	<description>
	
	   <![CDATA[ Dual antiplatelet therapy did not significantly reduce vein graft intimal hyperplasia compared with aspirin alone over 12 months.  ]]>
	
	</description>
	<pubDate>
	Tue, 17 Nov 2009 09:00:24 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1024575.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1024539.do</link>
	<title>HEAAL: High-dose trumps low-dose ARB for heart failure in the ACE-inhibitor intolerant  </title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED WITH COMMENTARY </i></b>// The randomized trial, which compared losartan dosages of 150 mg/day and 50 mg/day, "makes a strong case for the value of incremental inhibition of the renin-angiotensin system," its authors say.   ]]>
	
	</description>
	<pubDate>
	Tue, 17 Nov 2009 08:15:58 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1024539.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1024429.do</link>
	<title>FAIR-HF: Symptom improvement, functional gains follow correction of iron deficiency in heart failure</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED WITH COMMENTARY</i></b> // The randomized, placebo-controlled study's intriguing wrinkle: the benefits after 24 weeks of treatment with an injectable form of iron were independent of whether the patients were anemic.   ]]>
	
	</description>
	<pubDate>
	Tue, 17 Nov 2009 08:00:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1024429.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1024467.do</link>
	<title>HeartMate II continuous-flow VAD sets new benchmark in destination-therapy trial</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED WITH COMMENTARY</i></b> // Thoratec's HeartMate II continuous-flow VAD keeps about half of patients alive and stroke- or reintervention-free after two years in pivotal destination therapy trial. ]]>
	
	</description>
	<pubDate>
	Tue, 17 Nov 2009 08:00:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1024467.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1024153.do</link>
	<title>Bypassing the blues: How simple collaborative care can help tackle depression after CABG surgery</title>
	<description>
	
	   <![CDATA[ Depression after coronary artery bypass surgery is often overlooked by physicians but is associated with worse outcomes. A new US study illustrates a simple telephone-based approach to tackle this, with nurses encouraging patients to seek help from their primary-care doctors and providing ongoing feedback and review.  ]]>
	
	</description>
	<pubDate>
	Mon, 16 Nov 2009 18:45:23 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1024153.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1024017.do</link>
	<title>Postop anemia in high-CV-risk patients: No CV gains from fixed hemoglobin target in trial</title>
	<description>
	
	   <![CDATA[ A randomized trial found no protection from in-hospital cardiovascular events with a strategy of blood transfusions to maintain hemoglobin above 10 g/dL, compared with a more conservative approach to transfusion therapy, in patients with CV disease or risk factors who underwent hip surgery.   ]]>
	
	</description>
	<pubDate>
	Mon, 16 Nov 2009 17:45:01 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1024017.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1023939.do</link>
	<title>RECORD AF: Better success with rhythm control, but no difference in outcomes</title>
	<description>
	
	   <![CDATA[ New registry data presented this week showed that cardiologists are more likely to select rhythm control over rate control for the treatment of atrial fibrillation, and this strategy is more likely to lead to successful treatment of AF than the rate-control-based approach. Both strategies are equivalent in terms of their effect on clinical outcomes. ]]>
	
	</description>
	<pubDate>
	Mon, 16 Nov 2009 17:00:40 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1023939.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1023869.do</link>
	<title>Massachusetts data show similar STEMI PCI outcomes in hospitals with or without surgery </title>
	<description>
	
	   <![CDATA[ Data from a Massachusetts registry add to the growing evidence that hospitals without bypass-surgery capabilities can match the acute coronary intervention outcomes of surgery-on-site centers.  ]]>
	
	</description>
	<pubDate>
	Mon, 16 Nov 2009 16:15:48 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1023869.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1023633.do</link>
	<title>Cangrelor in CHAMPION: What went wrong? </title>
	<description>
	
	   <![CDATA[ Discussion is abounding on why cangrelor did not show benefit over clopidogrel despite the fact that it did inhibit platelet activity more effectively.  ]]>
	
	</description>
	<pubDate>
	Mon, 16 Nov 2009 15:15:27 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1023633.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1022387.do</link>
	<title>Plasma renin activity associated with cardiovascular events and mortality in HOPE</title>
	<description>
	
	   <![CDATA[ Patients with elevated baseline plasma renin activity levels had a twofold increased risk of total or cardiovascular mortality compared with those with low levels, and the strength of the association persisted after multiple adjustments, including the HOPE score, CRP, and BNP.  ]]>
	
	</description>
	<pubDate>
	Mon, 16 Nov 2009 14:45:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1022387.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1023533.do</link>
	<title>Medical device correction issued for Cardiac Science AEDs </title>
	<description>
	
	   <![CDATA[ AEDs manufactured by Cardiac Science are undergoing a nationwide voluntary medical device correction<b> </b>because of the potential failure of these devices to deliver therapy during use. ]]>
	
	</description>
	<pubDate>
	Mon, 16 Nov 2009 13:00:24 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1023533.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1023209.do</link>
	<title>REPLACE registry finds 15.3% six-month complication rate with pacer and ICD lead replacements</title>
	<description>
	
	   <![CDATA[ The REPLACE registry finds "sobering" comprehensive risk rates with pacemaker and ICD upgrades. ]]>
	
	</description>
	<pubDate>
	Mon, 16 Nov 2009 09:30:42 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1023209.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1023119.do</link>
	<title>PRINCE: Prehospital intranasal cooling after cardiac arrest feasible, may improve survival </title>
	<description>
	
	   <![CDATA[ A device that allows therapeutic hypothermia to begin in the field has been shown to be safe and its use feasible in treating out-of-hospital cardiac arrest.  ]]>
	
	</description>
	<pubDate>
	Mon, 16 Nov 2009 08:45:41 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1023119.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1022873.do</link>
	<title>Good news continues for ticagrelor in PLATO STEMI subanalysis </title>
	<description>
	
	   <![CDATA[ Ticagrelor, an investigational antiplatelet agent, may become a new standard of care for the management of patients with STEMI heading for primary PCI, said the lead investigator of the STEMI subset of the PLATO trial. Reporting the new findings here today, he said they were consistent with the overall PLATO results.  ]]>
	
	</description>
	<pubDate>
	Sun, 15 Nov 2009 19:30:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1022873.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1022265.do</link>
	<title>ARBITER 6-HALTS: HDL raising with niacin superior to ezetimibe </title>
	<description>
	
	   <![CDATA[ Extended-release niacin is superior to ezetimibe in its effect on carotid intima-media thickness. While experts say the trial tells clinicians little about ezetimibe, it is a big win for niacin given the substantial regression of atherosclerosis observed at eight and 14 months.  ]]>
	
	</description>
	<pubDate>
	Sun, 15 Nov 2009 18:00:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1022265.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1022323.do</link>
	<title>PACE: BiV pacing protects against RV pacing&#39;s adverse ventricular effects in randomized trial   </title>
	<description>
	
	   <![CDATA[ In patients with conventional indications for pacing and normal systolic function, preservation of synchrony with biventricular pacing prevented the adverse remodeling effects of right-ventricular-only pacing. But some question the trial's methods.   ]]>
	
	</description>
	<pubDate>
	Sun, 15 Nov 2009 16:30:23 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1022323.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1021875.do</link>
	<title>POPULARity contest: For platelet function assays, what works, what doesn&#39;t</title>
	<description>
	
	   <![CDATA[ None of the eight platelet assays studied were able to predict bleeding, but four of the eight, based on ADP-induced platelet aggregation, produced results that correlated with adverse CV outcomes. By contrast, four tests that use shear-stress-induced adhesion-based methods were not predictive. ]]>
	
	</description>
	<pubDate>
	Sun, 15 Nov 2009 14:15:02 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1021875.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1021669.do</link>
	<title>PEPCAD-3: Paclitaxel-coated-balloon/stent system misses mark in de novo coronary lesions</title>
	<description>
	
	   <![CDATA[ Inflation of the paclitaxel-delivering balloon followed by a bare-metal stent failed a randomized noninferiority test against the Cypher sirolimus-eluting stent in previously untreated coronary lesions.   ]]>
	
	</description>
	<pubDate>
	Sun, 15 Nov 2009 10:30:25 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1021669.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1021541.do</link>
	<title>FRANCE: Transcatheter-valve registry permits &quot;observation&quot; of CoreValve, Sapien differences</title>
	<description>
	
	   <![CDATA[ Results from one of the first registries to evaluate contemporary use of both the Edwards Sapien transcatheter valve and the CoreValve bioprosthesis show that complication rates are low and similar, following a short training period, and that mortality, at least out to six months, is "acceptable" for both types of devices.  ]]>
	
	</description>
	<pubDate>
	Sun, 15 Nov 2009 09:45:44 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1021541.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1020935.do</link>
	<title>Canadian confusion: Primary-care docs lack knowledge of CVD risk factors, prevention</title>
	<description>
	
	   <![CDATA[ Family doctors and general practitioners in Canada are confused about cardiovascular risk assessment in primary prevention, a new survey reveals.   ]]>
	
	</description>
	<pubDate>
	Sun, 15 Nov 2009 09:00:30 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1020935.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1021493.do</link>
	<title>Two-year EXPIRA results suggest mechanical aspiration with primary PCI may reduce mortality</title>
	<description>
	
	   <![CDATA[ Two-year follow-up results from the EXPIRA study show mechanical thrombectomy during primary PCI improves myocardial perfusion and may reduce mortality. ]]>
	
	</description>
	<pubDate>
	Sun, 15 Nov 2009 09:00:03 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1021493.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1021445.do</link>
	<title>Experienced operators can switch easily and rapidly to radial-access PCI: RAPTOR</title>
	<description>
	
	   <![CDATA[ Experienced interventional cardiologists can rapidly shift their practice from the femoral-artery to the radial-access approach, with no increase in procedure time and radiation exposure for PCI. Also, the transradial approach leads to a more economic use of hospital resources, say researchers. ]]>
	
	</description>
	<pubDate>
	Sun, 15 Nov 2009 08:30:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1021445.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1021415.do</link>
	<title>CHAMPION: Negative trials but some positive angles for cangrelor?</title>
	<description>
	
	   <![CDATA[ Although neither CHAMPION-PCI nor CHAMPION-PLATFORM showed significant reductions in the primary end point with this new IV antiplatelet agent, some positive effects were seen, suggesting that the drug may yet have a future.  ]]>
	
	</description>
	<pubDate>
	Sun, 15 Nov 2009 08:00:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1021415.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1021251.do</link>
	<title>Natural ventricular rate a powerful risk predictor in ICD trial </title>
	<description>
	
	   <![CDATA[ It's routinely assessed but underappreciated as a risk marker: the natural, unpaced heart rate of patients with implanted defibrillators was a strong, independent predictor of poor clinical outcomes in a retrospective analysis. ]]>
	
	</description>
	<pubDate>
	Thu, 12 Nov 2009 17:15:47 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1021251.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1021099.do</link>
	<title>William Ganz, innovative cardiologist, scientist, and inventor, dies</title>
	<description>
	
	   <![CDATA[ Pioneering interventional cardiologist William Ganz dies.  ]]>
	
	</description>
	<pubDate>
	Thu, 12 Nov 2009 15:15:08 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1021099.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1020999.do</link>
	<title>SGR repair bill failure could cool physician support for healthcare reform</title>
	<description>
	
	   <![CDATA[ Now that the US House of Representatives has passed a healthcare reform bill, organized medicine anticipates another vote&#151;possibly next week&#151;on a second bill that would rewrite Medicare's controversial sustainable-growth-rate formula for physician reimbursement. ]]>
	
	</description>
	<pubDate>
	Thu, 12 Nov 2009 15:00:58 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1020999.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1020973.do</link>
	<title>DES fractures occur more often than thought </title>
	<description>
	
	   <![CDATA[ A new postmortem study using high-resolution imaging has found that fractures in drug-eluting stents may be more common than thought. However, the majority of such fractures appear to be low-grade and silent, with likely few clinical implications, say the researchers.  ]]>
	
	</description>
	<pubDate>
	Thu, 12 Nov 2009 13:15:57 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1020973.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1020861.do</link>
	<title>Total- and HDL-cholesterol levels, not triglycerides, predict vascular risk</title>
	<description>
	
	   <![CDATA[ Clinicians can simplify their existing risk-assessment tools by measuring either total- and HDL-cholesterol levels or apolipoproteins, and this assessment can effectively be done in patients who did not fast before the test. ]]>
	
	</description>
	<pubDate>
	Thu, 12 Nov 2009 10:00:40 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1020861.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1020777.do</link>
	<title>ASTRAL finds no benefit of revascularization over medical therapy alone for renal-artery stenosis</title>
	<description>
	
	   <![CDATA[ Percutaneous revascularization of atherosclerotic renal arteries improves patency, but its benefits on renal function have been evaluated only in small studies. The 806-patient ASTRAL trial found no evidence of benefit from revascularization. ]]>
	
	</description>
	<pubDate>
	Wed, 11 Nov 2009 17:00:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1020777.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1020675.do</link>
	<title>FDA investigating external-defib energy levels </title>
	<description>
	
	   <![CDATA[ The agency is following up on 14 reports over the past three years of unsuccessful defibrillation/cardioversion attempts from a 200-J device followed by successful therapy from a 360-J unit.    ]]>
	
	</description>
	<pubDate>
	Wed, 11 Nov 2009 11:45:30 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1020675.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1020585.do</link>
	<title>Regions with high rates of carotid-stenting adoption have poorer outcomes</title>
	<description>
	
	   <![CDATA[ Results from a new study suggest that, as the use of carotid artery stenting has become more widespread following expanded Medicare coverage, overall revascularization outcomes have worsened. ]]>
	
	</description>
	<pubDate>
	Wed, 11 Nov 2009 11:15:28 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1020585.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1020447.do</link>
	<title>What&#39;s going to be hot at AHA 2009? </title>
	<description>
	
	   <![CDATA[ Anticipation is building for full trial results from ARBITER 6-HALTS, plus a better understanding of what went wrong with cangrelor in the CHAMPION trials. Also in the lineup are updates from PLATO, RE-LY, ALLHAT, BARI 2D, STICH, CASCADE, POPULAR, HEARTMATE II, and many more. Indeed, this year's "late-breaking" sessions include more than 30 trials over five days.  ]]>
	
	</description>
	<pubDate>
	Wed, 11 Nov 2009 09:00:54 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1020447.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1020311.do</link>
	<title>Walking speed predicts CV mortality in older people </title>
	<description>
	
	   <![CDATA[ Fast walkers should find themselves less likely to succumb to cardiovascular death, according to a new French study in older adults. Measuring general fitness in this way could easily be incorporated into a general global assessment of cardiovascular risk, say the researchers.  ]]>
	
	</description>
	<pubDate>
	Tue, 10 Nov 2009 19:01:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1020311.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1020401.do</link>
	<title>No benefits of aspirin for primary prevention in diabetics, meta-analysis suggests </title>
	<description>
	
	   <![CDATA[ Most guideline documents recommend aspirin for primary prevention in people with diabetes, but a new meta-analysis has found no benefit of the widely used drug across a range of different cardiovascular end points. The results speak to the need for dedicated randomized trials, investigators say.  ]]>
	
	</description>
	<pubDate>
	Tue, 10 Nov 2009 17:15:54 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1020401.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1020347.do</link>
	<title>Clopidogrel effects in men vs women </title>
	<description>
	
	   <![CDATA[ A new meta-analysis has suggested that clopidogrel reduces cardiovascular events and increases bleeding in both men and women, without significant differences between the sexes.  ]]>
	
	</description>
	<pubDate>
	Tue, 10 Nov 2009 16:15:59 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1020347.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1020213.do</link>
	<title>One in four discharged after heart-failure hospitalization are back within a month </title>
	<description>
	
	   <![CDATA[ What's behind the high rehospitalization rate, the same one seen year after year, for patients discharged after a hospitalization for heart failure, in an analysis covering three years of Medicare data? The authors propose one reason. ]]>
	
	</description>
	<pubDate>
	Tue, 10 Nov 2009 16:00:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1020213.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1020287.do</link>
	<title>Class I recall of CardioVations EndoClamp catheters</title>
	<description>
	
	   <![CDATA[ Edwards's September 24 recall of balloon catheters used in bypass surgery has been categorized as a class I recall by the FDA. ]]>
	
	</description>
	<pubDate>
	Tue, 10 Nov 2009 12:45:21 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1020287.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1020243.do</link>
	<title>Echocardiographic evidence of PAH often doesn&#39;t trigger referral to a specialist</title>
	<description>
	
	   <![CDATA[ Only one in four patients with echocardiographic evidence of pulmonary arterial hypertension is being referred for further evaluation. ]]>
	
	</description>
	<pubDate>
	Tue, 10 Nov 2009 11:00:48 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1020243.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1020051.do</link>
	<title>Ambrisentan effective long-term for pulmonary arterial hypertension </title>
	<description>
	
	   <![CDATA[ New data from the extension phase of two pivotal trials of the endothelin-receptor antagonist ambrisentan support its use as part of a long-term strategy for the treatment of pulmonary arterial hypertension. ]]>
	
	</description>
	<pubDate>
	Mon, 09 Nov 2009 17:00:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1020051.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1019709.do</link>
	<title>CT angiography shows coronary plaque progression</title>
	<description>
	
	   <![CDATA[ Coronary plaque burden in patients with acute chest pain increases significantly over two years. A new Harvard study evaluates CTA as a tool to follow the progression. ]]>
	
	</description>
	<pubDate>
	Mon, 09 Nov 2009 17:00:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1019709.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1019965.do</link>
	<title>Obesity may top hypertension as risk factor for LA enlargement</title>
	<description>
	
	   <![CDATA[ Obesity and hypertension were major independent risk factors for left atrial enlargement (itself a risk factor for atrial fibrillation) in an observational, population-based study, but obesity was the strongest predictor.  ]]>
	
	</description>
	<pubDate>
	Mon, 09 Nov 2009 17:00:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1019965.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1020115.do</link>
	<title>DE-MRI shows which myocardial injury is irreversible </title>
	<description>
	
	   <![CDATA[ Distinguishing myocardial scarring with MRI may help predict LV functional recovery. ]]>
	
	</description>
	<pubDate>
	Mon, 09 Nov 2009 16:00:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1020115.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1019789.do</link>
	<title>US House passes healthcare reform bill</title>
	<description>
	
	   <![CDATA[ In the face of near-unanimous Republican opposition and a last-ditch effort to change the bill, the US House of Representatives voted in favor of legislation to overhaul the nation's healthcare system. ]]>
	
	</description>
	<pubDate>
	Mon, 09 Nov 2009 10:00:15 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1019789.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1019761.do</link>
	<title>Interventional cardiologist Donald Baim dies </title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED </i></b>// Interventional cardiologist Dr Donald Baim, chief medical and scientific officer at Boston Scientific, has died. ]]>
	
	</description>
	<pubDate>
	Fri, 06 Nov 2009 18:22:01 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1019761.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1019675.do</link>
	<title>Latest European and US STEMI guidelines compared and contrasted </title>
	<description>
	
	   <![CDATA[ The latest recommendations for the treatment of ST-elevation MI issued by American cardiology associations and the European Society of Cardiology are compared and contrasted in a new paper.  ]]>
	
	</description>
	<pubDate>
	Fri, 06 Nov 2009 17:15:26 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1019675.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1019651.do</link>
	<title>Enrollment halts in randomized trial of CPR for out-of-hospital arrest</title>
	<description>
	
	   <![CDATA[ No survival differences after out-of-hospital cardiac arrest were seen at a preliminary DSMB review in the ROC PRIMED trial, which compared early vs delayed post-CPR assessment for defibrillation and tested the effectiveness of a device for optimizing intrathoracic pressure during CPR.    ]]>
	
	</description>
	<pubDate>
	Fri, 06 Nov 2009 16:00:39 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1019651.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1019439.do</link>
	<title>Medicaid access to smoking cessation falls short</title>
	<description>
	
	   <![CDATA[ A national survey shows that although the majority of state Medicaid programs offer coverage for some form of tobacco-dependence treatment, most fall far short of a stated mandate to provide unrestricted access to approved therapies. ]]>
	
	</description>
	<pubDate>
	Thu, 05 Nov 2009 17:30:46 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1019439.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1019417.do</link>
	<title>Serum phosphorous, kidney function predict CAC</title>
	<description>
	
	   <![CDATA[ The Spokane Heart Study finds a connection between kidney function, serum phosphorus, and the risk of coronary artery calcification. ]]>
	
	</description>
	<pubDate>
	Thu, 05 Nov 2009 17:00:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1019417.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1019315.do</link>
	<title>Low-cholesterol/cancer studies should &quot;dispel lingering doubts&quot; of causal link </title>
	<description>
	
	   <![CDATA[ Two new papers should help put to rest concerns that low serum cholesterol levels may increase cancer risk.  ]]>
	
	</description>
	<pubDate>
	Thu, 05 Nov 2009 14:15:24 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1019315.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1019233.do</link>
	<title>Not all metabolic syndrome is created equal: Framingham Offspring analysis</title>
	<description>
	
	   <![CDATA[ The syndrome (defined by ATP III criteria) can predict increased cardiovascular and mortality risk or not, depending on which three of five risk factors contributed to the diagnosis, a cohort study suggests; its investigators caution that their observations are only preliminary.   ]]>
	
	</description>
	<pubDate>
	Thu, 05 Nov 2009 11:45:03 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1019233.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1019179.do</link>
	<title>Prehospital triage &quot;immediately successful&quot; in boosting rates of thrombolytic therapy for stroke</title>
	<description>
	
	   <![CDATA[ Toronto researchers report that a citywide prehospital protocol raised their rates of thrombolytic treatment to among the highest in North America, underlining, they say, the critical importance of organized stroke care.   ]]>
	
	</description>
	<pubDate>
	Thu, 05 Nov 2009 11:00:44 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1019179.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1019089.do</link>
	<title>Better survival in hospitalized flu patients on statins</title>
	<description>
	
	   <![CDATA[ Statin users hospitalized for influenza experienced a 54% lower risk of death compared with patients not taking statins.  ]]>
	
	</description>
	<pubDate>
	Wed, 04 Nov 2009 17:30:28 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1019089.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1019025.do</link>
	<title>Off-pump CABG shows no benefit over on-pump approach: ROOBY study</title>
	<description>
	
	   <![CDATA[ A 2203-patient randomized trial of off-pump vs on-pump CABG surgery found no differences in neuropsychological outcomes and worse overall outcomes for the off-pump group at one-year follow-up. ]]>
	
	</description>
	<pubDate>
	Wed, 04 Nov 2009 17:00:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1019025.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1018999.do</link>
	<title>VELETI in print: Plaque sealing of SVGs a strategy &quot;ahead of its time&quot;?</title>
	<description>
	
	   <![CDATA[ The imaging study was the first to show that stenting a non-flow-limiting stenosis of an SVG may help slow or halt the accelerated atherosclerosis that takes place in these vessels. An accompanying editorial cautions that the study does little more than "infer a trend toward anatomic benefit."  ]]>
	
	</description>
	<pubDate>
	Wed, 04 Nov 2009 15:30:23 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1018999.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1018939.do</link>
	<title>Adding fuel to the J-curve fire; debate is reignited </title>
	<description>
	
	   <![CDATA[ More discussion about the J-curve in hypertension is published this week; one expert believes the undue attention being paid to this subject might discourage doctors from treating high blood pressure aggressively. ]]>
	
	</description>
	<pubDate>
	Wed, 04 Nov 2009 14:30:56 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1018939.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1018889.do</link>
	<title>No CV risk reduction with B vitamins posttransplant </title>
	<description>
	
	   <![CDATA[ In keeping with all the other evidence showing no effects of homocysteine-lowering with B vitamins, the FAVORIT study now confirms that this lack of benefit is also seen in renal-transplant recipients.   ]]>
	
	</description>
	<pubDate>
	Wed, 04 Nov 2009 13:15:27 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1018889.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1018751.do</link>
	<title>Another in-hospital CV risk marker: 24-hour shifts with overnight on-call duty </title>
	<description>
	
	   <![CDATA[ Long work shifts with nighttime on-call duty, with the inevitable interruptions of sleep, are associated with ECG, blood-pressure, and biochemical changes associated with increased cardiovascular risk, suggests a randomized crossover study that hints at a sustained effect on the risk markers if the 24-hour shifts happen too frequently.   ]]>
	
	</description>
	<pubDate>
	Wed, 04 Nov 2009 09:45:43 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1018751.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1018713.do</link>
	<title>CAC scoring plus SPECT provide long and short view of cardiac risk</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED </i></b>// An 1126-patient trial shows that SPECT and CAC scoring imaging tests are independent and complementary predictors of short- and long-term cardiac risk, respectively. ]]>
	
	</description>
	<pubDate>
	Tue, 03 Nov 2009 17:00:51 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1018713.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1018685.do</link>
	<title>Interventional cardiologist sues hospital under Whistleblower&#39;s Act </title>
	<description>
	
	   <![CDATA[ Dr David Gossman has filed a lawsuit claiming that he was fired for complaining about ties between the hospital and some of its senior staff with the medical device company Medtronic.  ]]>
	
	</description>
	<pubDate>
	Tue, 03 Nov 2009 15:15:34 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1018685.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1018639.do</link>
	<title>US updates advice on perioperative beta-blocker use in noncardiac surgery </title>
	<description>
	
	   <![CDATA[ A US update on the perioperative use of beta blockers for noncardiac surgery is, says the lead author,  "similar" to recent European guidance on this issue. ]]>
	
	</description>
	<pubDate>
	Tue, 03 Nov 2009 14:30:32 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1018639.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1018593.do</link>
	<title>FDA expands exenatide use; warns of renal-failure risk</title>
	<description>
	
	   <![CDATA[ The FDA has issued a warning about exenatide the same day the agency approved its first-line use along with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus. ]]>
	
	</description>
	<pubDate>
	Tue, 03 Nov 2009 13:15:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1018593.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1018537.do</link>
	<title>CMS set to cut Medicare physician fees for cardiovascular imaging </title>
	<description>
	
	   <![CDATA[ The 2010 Medicare Physician Fee Schedule final rule released by the CMS makes major cuts to several cardiovascular imaging services. ]]>
	
	</description>
	<pubDate>
	Tue, 03 Nov 2009 11:45:09 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1018537.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1018387.do</link>
	<title>CORONA analysis reopens door for statins in heart failure </title>
	<description>
	
	   <![CDATA[ Statins for heart failure? After they failed to show much effect in two large randomized trials? Yes&#151;maybe; at least in patients with ischemic heart failure who start the drugs early enough, suggests a post hoc analysis based on one of the trials. ]]>
	
	</description>
	<pubDate>
	Tue, 03 Nov 2009 10:45:33 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1018387.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1018109.do</link>
	<title>Combined home/GP hypertension control program successful in Pakistan </title>
	<description>
	
	   <![CDATA[ A synergistic approach of educating general practitioners about hypertension control together with a program to send lay workers into people's homes to educate them about the management of high blood pressure has proven successful in low- to middle-income households in Pakistan.  ]]>
	
	</description>
	<pubDate>
	Mon, 02 Nov 2009 17:00:00 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1018109.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1017689.do</link>
	<title>Advocates build support for Canadian Heart Health Strategy in a difficult environment</title>
	<description>
	
	   <![CDATA[ Supporters of the Canadian Heart Health Strategy and Action Plan continue to solicit support from physicians and the public for a comprehensive strategy for improving Canadian's heart health at both the provincial and federal level. ]]>
	
	</description>
	<pubDate>
	Mon, 02 Nov 2009 11:15:59 EST
	</pubDate>
	<guid>http://test.theheart.org/article/1017689.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1017579.do</link>
	<title>No TREAT: Darbepoetin alfa fails to reduce CV or renal events in anemic diabetics with CKD </title>
	<description>
	
	   <![CDATA[ No differences were seen between groups, except in strokes, which were twice as high in the active-treatment group. Anticipated improvements in fatigue scores were modest and not clinically meaningful, investigators say.  ]]>
	
	</description>
	<pubDate>
	Fri, 30 Oct 2009 20:41:45 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1017579.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1017525.do</link>
	<title>Blood type of pig may be factor in longevity of porcine replacement heart valves</title>
	<description>
	
	   <![CDATA[ Researchers in Ottawa find that the longevity of porcine replacement heart valves may depend partly on whether the blood type of the patient matches the blood type of the valve's "original owner." ]]>
	
	</description>
	<pubDate>
	Fri, 30 Oct 2009 16:45:00 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1017525.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1017487.do</link>
	<title>Imaging study shows plaque regression with niacin vs placebo </title>
	<description>
	
	   <![CDATA[ Just weeks before ARBITER-HALTS 6 results come out at AHA 2009, an MRI study suggests that niacin is better than placebo in statin-treated patients with low HDL, at least for reducing carotid wall area. Experts say they'd also like to see insights into niacin effects on lipid-rich plaque volumes&#151;the more commonly seen end point with MRI.  ]]>
	
	</description>
	<pubDate>
	Fri, 30 Oct 2009 16:00:00 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1017487.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1017341.do</link>
	<title>Lifestyle-based diabetes prevention seen to endure for at least a decade</title>
	<description>
	
	   <![CDATA[ The protective effects of diet modification, exercise, and other lifestyle changes against new-onset diabetes showcased in the three-year Diabetes Prevention Program continued out to 10 years in a follow-up analysis.    ]]>
	
	</description>
	<pubDate>
	Fri, 30 Oct 2009 10:00:00 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1017341.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1017153.do</link>
	<title>Combination drugs for weight loss</title>
	<description>
	
	   <![CDATA[ Two studies presented this week have shown positive effects on weight loss using a combination of agents. ]]>
	
	</description>
	<pubDate>
	Thu, 29 Oct 2009 15:30:33 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1017153.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1017037.do</link>
	<title>Benefits of targeted lead placement with CRT devices supported by long-term mortality data</title>
	<description>
	
	   <![CDATA[ An additional year of data from the INCREMENTAL study showed that echo-targeted LV lead positioning increased the likelihood of a response to device therapy by about 40% over standard lead placement. But does that difference translate into better long-term outcomes for the patient? ]]>
	
	</description>
	<pubDate>
	Thu, 29 Oct 2009 15:00:55 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1017037.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1016897.do</link>
	<title>CRP predicts mortality and MI, but not stroke</title>
	<description>
	
	   <![CDATA[ A new analysis from the Northern Manhattan Study finds that high-sensitivity C-reactive protein was modestly associated with mortality and MI but not ischemic stroke in this multiethnic population, suggesting the predictive value may depend on other factors.  ]]>
	
	</description>
	<pubDate>
	Thu, 29 Oct 2009 12:00:54 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1016897.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1016975.do</link>
	<title>First trial of viral-derived protein agent shows promise as anti-inflammatory ACS therapy</title>
	<description>
	
	   <![CDATA[ Inflammatory responses contribute to coronary plaque rupture, thrombosis, and vascular occlusion. Some viruses have proteins that interfere with these inflammatory responses. Researchers have identified a viral-derived protein that may eventually be an anti-inflammatory treatment for coronary syndromes. ]]>
	
	</description>
	<pubDate>
	Thu, 29 Oct 2009 11:45:16 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1016975.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1016867.do</link>
	<title>Sex differences in changing MI prevalence, mortality challenge conventional wisdom </title>
	<description>
	
	   <![CDATA[ Two well-known observational registries highlight such changes in women and men over a decade or more: Do women younger than 55 still have an advantage over men in the same age group? ]]>
	
	</description>
	<pubDate>
	Thu, 29 Oct 2009 10:30:28 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1016867.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1016067.do</link>
	<title>Underutilization of ICDs in CABG patients is worst in women and elderly, Halifax study shows</title>
	<description>
	
	   <![CDATA[ Only 101 of 1169 post-bypass-surgery patients eligible for an ICD got one over a 13-year period in Nova Scotia.  ]]>
	
	</description>
	<pubDate>
	Wed, 28 Oct 2009 16:45:37 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1016067.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1016657.do</link>
	<title>Schizophrenia plus diabetes linked with higher CAD yet lower revascularization rates</title>
	<description>
	
	   <![CDATA[ Individuals with schizophrenia and diabetes&#151;as opposed to diabetes only&#151;have a greater risk of CAD but a smaller likelihood of receiving CABG or PCI, a large cohort study suggests. ]]>
	
	</description>
	<pubDate>
	Wed, 28 Oct 2009 16:30:56 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1016657.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1016585.do</link>
	<title>Bariatric surgery fails to reduce risk of MI long term</title>
	<description>
	
	   <![CDATA[ After a median follow-up of 12 years, MI rates were essentially the same among those treated with surgery and those who received conventional care for weight loss. ]]>
	
	</description>
	<pubDate>
	Wed, 28 Oct 2009 14:30:14 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1016585.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1016557.do</link>
	<title>Non-CV mortality also important in dialysis patients</title>
	<description>
	
	   <![CDATA[ Physicians may tend to overlook risk factors for noncardiovascular mortality in patients starting dialysis, since the emphasis in the past has always been on cardiovascular risk, researchers say.  ]]>
	
	</description>
	<pubDate>
	Wed, 28 Oct 2009 14:15:19 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1016557.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1016353.do</link>
	<title>Lorcaserin passes weight-loss and valvular hurdles in BLOSSOM study</title>
	<description>
	
	   <![CDATA[ Among overweight patients, including those with preexisting echocardiographic valvulopathy, the average weight loss was approximately 5 kg with lorcaserin. Importantly, there were no concerns raised about new or worsening cardiac valve problems with the 5HT2C-receptor agonist. ]]>
	
	</description>
	<pubDate>
	Tue, 27 Oct 2009 16:15:27 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1016353.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1016171.do</link>
	<title>Contrary to common belief, women feel same heart-attack symptoms as men</title>
	<description>
	
	   <![CDATA[ Women and men have the same rates of chest pain and other classic symptoms during ACS, although women are more likely to experience some other symptoms such as jaw and neck pain. ]]>
	
	</description>
	<pubDate>
	Tue, 27 Oct 2009 14:30:23 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1016171.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1015869.do</link>
	<title>Stent pioneer Julio Palmaz urges DES makers to &quot;learn from mistakes of the past&quot; </title>
	<description>
	
	   <![CDATA[ Speaking at the 30th anniversary of the GISE Congress, Palmaz said he'd never believed drug elution was the way forward for stents and outlined his theories for why coatings of any kind disrupt the healing properties of metallic coronary stents. ]]>
	
	</description>
	<pubDate>
	Tue, 27 Oct 2009 13:00:38 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1015869.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1015993.do</link>
	<title>Blood products should be used conservatively in heart-surgery patients, trial shows</title>
	<description>
	
	   <![CDATA[ Administration of blood products to stable patients post-cardiac surgery increases their risk of death, renal failure, and sepsis, according to new research. ]]>
	
	</description>
	<pubDate>
	Tue, 27 Oct 2009 12:15:25 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1015993.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1015749.do</link>
	<title>ACCORD update: &quot;One size fits all&quot; may not be best glucose-lowering strategy </title>
	<description>
	
	   <![CDATA[ While post hoc analyses of ACCORD data suggest there are subgroups of diabetic patients who may not benefit from an aggressive glucose-lowering approach, similar analyses with ADVANCE data did not identify subgroup differences.    ]]>
	
	</description>
	<pubDate>
	Tue, 27 Oct 2009 10:00:02 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1015749.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1015787.do</link>
	<title>Experts weigh in on calorie lists on menus, despite &quot;mixed&quot; science</title>
	<description>
	
	   <![CDATA[ Results showing that people eat less when they know how many calories are in that Big Mac are mixed, but experts say that menu labeling provides only upside, with no public-health cost, and that over time results will show the information to have a positive effect on obesity rates in the US. ]]>
	
	</description>
	<pubDate>
	Mon, 26 Oct 2009 16:45:21 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1015787.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1015565.do</link>
	<title>Distribution of body fat important in VTE </title>
	<description>
	
	   <![CDATA[ The distribution of body fat, as well as the amount, is important when it comes to the risk of venous thromboembolism, Danish researchers have discovered.  ]]>
	
	</description>
	<pubDate>
	Mon, 26 Oct 2009 16:00:00 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1015565.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1015489.do</link>
	<title>NRMI data raise more questions about PCI in nonsurgery centers</title>
	<description>
	
	   <![CDATA[ A new analysis of national registry data suggests that the superior outcomes of NSTEMI patients in hospitals with open-heart-surgery capabilities vs those without it are due to their size, procedure volume, and adherence to medication guidelines.  ]]>
	
	</description>
	<pubDate>
	Mon, 26 Oct 2009 13:00:23 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1015489.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1015367.do</link>
	<title>Less exposure to cardiovascular risk factors with intensive diabetes intervention: Look AHEAD </title>
	<description>
	
	   <![CDATA[ Intensive lifestyle intervention in the management of diabetes produces sustained weight loss and improvements in fitness, as well as improvements in glycemic control, systolic blood pressure, and HDL-cholesterol levels. ]]>
	
	</description>
	<pubDate>
	Mon, 26 Oct 2009 10:00:00 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1015367.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1015287.do</link>
	<title>New MESA data: Pericardial fat a better predictor of CHD than BMI </title>
	<description>
	
	   <![CDATA[ Pericardial fat, which is found around the heart, predicts future CHD events and may even be a better predictor of these than conventional obesity measures, such as BMI and waist circumference, a new study of MESA participants shows. ]]>
	
	</description>
	<pubDate>
	Fri, 23 Oct 2009 17:00:00 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1015287.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1015253.do</link>
	<title>NT-proBNP &quot;remarkable predictor&quot; of incident atrial fibrillation</title>
	<description>
	
	   <![CDATA[ The fact that elevated baseline NT-proBNP levels predict a diagnosis of AF even 16 years later suggests that peptide elevations precede the onset of arrhythmia, according to the researchers. ]]>
	
	</description>
	<pubDate>
	Fri, 23 Oct 2009 16:30:37 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1015253.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1015219.do</link>
	<title>New model connects low-dose radiation to CVD risk</title>
	<description>
	
	   <![CDATA[ Data from Japanese atomic-bomb survivors and people exposed to radiation in their jobs show that even low doses of ionizing radiation may contribute to cardiovascular disease risk. British researchers have created a complex mathematical model to better understand the relationship between radiation exposure and heart disease. ]]>
	
	</description>
	<pubDate>
	Fri, 23 Oct 2009 15:30:21 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1015219.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1015185.do</link>
	<title>Look at absolute event rates when interpreting trial results </title>
	<description>
	
	   <![CDATA[ The low event rate in the RECORD trial of rosiglitazone has led some to question the validity of the results.  ]]>
	
	</description>
	<pubDate>
	Fri, 23 Oct 2009 13:30:19 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1015185.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1015103.do</link>
	<title>NHLBI director Nabel named new president of Brigham and Women&#39;s Hospital</title>
	<description>
	
	   <![CDATA[ Brigham and Women's/Faulkner Hospitals in Boston names Dr Elizabeth G Nabel as its next president, effective January 1, 2010. ]]>
	
	</description>
	<pubDate>
	Fri, 23 Oct 2009 09:15:16 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1015103.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1014953.do</link>
	<title>GLP-1 analog liraglutide promising in obesity </title>
	<description>
	
	   <![CDATA[ A drug originally developed to treat diabetes may have promise as an obesity therapy, a new study shows. Those taking liraglutide, a GLP-1 analog, lost more weight than those on an established obesity medication, orlistat.  ]]>
	
	</description>
	<pubDate>
	Thu, 22 Oct 2009 18:30:00 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1014953.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1015021.do</link>
	<title>HCM transmitted by sperm donation: A case report</title>
	<description>
	
	   <![CDATA[ The donor, who was later shown to be affected by a novel beta-myosin heavy-chain mutation that causes HCM, is responsible for at least nine children known to be genetically affected with HCM. ]]>
	
	</description>
	<pubDate>
	Thu, 22 Oct 2009 15:45:36 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1015021.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1014997.do</link>
	<title>Glucose lowering in type 2 diabetes to prevent CVD remains controversial but still important</title>
	<description>
	
	   <![CDATA[ Although the case for intensive glucose lowering in diabetic patients to prevent CVD is not straightforward, glucose control is still important for other reasons, and blood pressure and lipid control should not be neglected, according to debaters at a diabetes meeting.   ]]>
	
	</description>
	<pubDate>
	Thu, 22 Oct 2009 14:45:51 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1014997.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1014853.do</link>
	<title>Simple cooling methods improve neurologic outcomes after cardiac arrest, new review confirms</title>
	<description>
	
	   <![CDATA[  A new literature review confirms that conventional cooling methods work safely to improve survival and reduce brain damage after cardiac arrest.  ]]>
	
	</description>
	<pubDate>
	Thu, 22 Oct 2009 11:00:03 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1014853.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1014799.do</link>
	<title>New analyses from ECASS 3 support use of tPA up to 4.5 hours after stroke</title>
	<description>
	
	   <![CDATA[ Investigators show benefits of thrombolysis after stroke across a variety of subgroups; although not all end points reached statistical significance, trends favored treatment with tPA. The message, though, remains to treat as soon as possible, they say. ]]>
	
	</description>
	<pubDate>
	Thu, 22 Oct 2009 08:30:55 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1014799.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1014703.do</link>
	<title>Iloprost prevents contrast-induced nephropathy in high-risk patients undergoing coronary intervention </title>
	<description>
	
	   <![CDATA[ Intravenously administered iloprost, a prostacyclin analog, may help prevent contrast-induced nephropathy in patients with renal dysfunction undergoing coronary procedures, a new pilot study suggests.  ]]>
	
	</description>
	<pubDate>
	Wed, 21 Oct 2009 13:00:34 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1014703.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1014607.do</link>
	<title>Current risk equations may overestimate CVD risk in diabetic patients </title>
	<description>
	
	   <![CDATA[ Researchers using different international databases report that the Framingham and UKPDS risk equations overestimate the probability of CV events in diabetic patients.  ]]>
	
	</description>
	<pubDate>
	Wed, 21 Oct 2009 10:00:31 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1014607.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1014445.do</link>
	<title>Cardiovascular disease increases risk of hip fracture </title>
	<description>
	
	   <![CDATA[ Swedish researchers have confirmed a link between stroke and subsequent hip fracture in older people and identified for the first time that a diagnosis of heart failure also increases the risk for this fracture. They also identify a large genetic component to this association, via their use of a twin registry. ]]>
	
	</description>
	<pubDate>
	Tue, 20 Oct 2009 16:00:00 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1014445.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1014201.do</link>
	<title>Just one-third of heart-failure patients receive aldosterone antagonists</title>
	<description>
	
	   <![CDATA[ Just one-third of hospitalized HF patients who meet the criteria for an aldosterone antagonist receive the drugs upon discharge. On the plus side, few patients with contraindications are prescribed the medication. ]]>
	
	</description>
	<pubDate>
	Tue, 20 Oct 2009 16:00:00 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1014201.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1014385.do</link>
	<title>Omega-3s no help to SSRI-treated CHD patients</title>
	<description>
	
	   <![CDATA[ The researchers suggest further study is still needed, as it is unclear whether higher doses of omega-3 fatty acids or setraline, longer treatment, or a different ratio of EPA to DHA would produce favorable results. ]]>
	
	</description>
	<pubDate>
	Tue, 20 Oct 2009 16:00:00 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1014385.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1014363.do</link>
	<title>Data from 1.23 million patients confirms warfarin increases mortality in trauma patients</title>
	<description>
	
	   <![CDATA[ Warfarin use is rising in both older and younger patients. How much does the anticoagulant contribute to the risk of traumatic injuries?  ]]>
	
	</description>
	<pubDate>
	Tue, 20 Oct 2009 13:45:55 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1014363.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1014307.do</link>
	<title>Thiazolidinediones have a role for appropriate diabetic patients</title>
	<description>
	
	   <![CDATA[ After 10 years of clinical use of TZDs, "we are still at the beginning," and randomized controlled trials shed light on their use in appropriate diabetic patients, speakers at a diabetes symposium reported.  ]]>
	
	</description>
	<pubDate>
	Tue, 20 Oct 2009 12:45:38 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1014307.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1014283.do</link>
	<title>Statin drugs lower costs and complications of aortic surgery</title>
	<description>
	
	   <![CDATA[ There are significant cost savings with statin therapy before abdominal aortic aneurysm repair, and the complication rate is less than half that of patients who do not receive preop statins. ]]>
	
	</description>
	<pubDate>
	Tue, 20 Oct 2009 11:30:57 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1014283.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1014153.do</link>
	<title>ACE inhibitors of benefit in ischemic heart disease patients with preserved LV function </title>
	<description>
	
	   <![CDATA[ Patients with ischemic heart disease and preserved LV function on standard therapy will gain additional benefit from taking ACE inhibitors, a new review concludes. The same cannot be said for ARBs, a drug class for which the evidence is much weaker, but these are a good substitute in those who cannot tolerate ACE inhibitors, the authors say.  ]]>
	
	</description>
	<pubDate>
	Mon, 19 Oct 2009 17:00:00 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1014153.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1014115.do</link>
	<title>Expanded indication for telmisartan</title>
	<description>
	
	   <![CDATA[ The drug can now be used to reduce the risk of MI, stroke, or death from cardiovascular causes in patients 55 years of age or older who are intolerant to ACE inhibitors but at high risk for cardiovascular events. ]]>
	
	</description>
	<pubDate>
	Mon, 19 Oct 2009 13:30:16 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1014115.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1014027.do</link>
	<title>TYCOON: One year of dual-antiplatelet therapy with DES isn&#39;t enough</title>
	<description>
	
	   <![CDATA[ New results from an Italian registry reopen the question of how long drug-eluting stent recipients should stay on a dual antiplatelet regimen to prevent late thrombosis.  ]]>
	
	</description>
	<pubDate>
	Mon, 19 Oct 2009 12:45:34 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1014027.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1013927.do</link>
	<title>Transfusion in acute HF: No extra mortality risk </title>
	<description>
	
	   <![CDATA[ Blood transfusions for anemia in acute decompensated heart failure don't exacerbate outcomes, as may happen in some ACS cases, suggests a one-year experience of hospitals in Israel. On the contrary . . .   ]]>
	
	</description>
	<pubDate>
	Mon, 19 Oct 2009 11:00:10 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1013927.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1013811.do</link>
	<title>Rosuvastatin cleared for pediatric FH</title>
	<description>
	
	   <![CDATA[ The FDA has approved rosuvastatin for use in children aged 10 to 17 years old with familial hypercholesterolemia. ]]>
	
	</description>
	<pubDate>
	Fri, 16 Oct 2009 16:30:01 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1013811.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1013773.do</link>
	<title>Smoking bans reduce the risk of acute coronary events: IOM report </title>
	<description>
	
	   <![CDATA[ IOM report confirms the cardiovascular benefit of implementing a ban on smoking in public places. The reduction in acute MI, anywhere from 6% to 47%, typically occurs quickly, often within 12 months of the ban. ]]>
	
	</description>
	<pubDate>
	Fri, 16 Oct 2009 16:00:09 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1013773.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1013593.do</link>
	<title>Zero CAC score not 100% reassuring in those presenting to ER with chest pain</title>
	<description>
	
	   <![CDATA[ In those presenting to the ER with chest pain, a prior zero calcium score cannot completely rule out a coronary obstruction, a new analysis of the MESA study has shown. This is likely due to the presence of soft plaques not detected by calcium screening, the researchers say. ]]>
	
	</description>
	<pubDate>
	Fri, 16 Oct 2009 12:45:08 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1013593.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1013515.do</link>
	<title>No link seen between heart failure and coffee intake</title>
	<description>
	
	   <![CDATA[ With few studies in the literature specifically looking at the issue, a prospective, population-based study in Sweden has found no significant rise or fall in risk of heart-failure hospitalization or death at increasing levels of coffee intake.    ]]>
	
	</description>
	<pubDate>
	Fri, 16 Oct 2009 10:15:02 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1013515.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1013467.do</link>
	<title>Can statins prevent and treat infection?</title>
	<description>
	
	   <![CDATA[ Results from a new meta-analysis show the pleiotropic effects of statins are useful in the treatment and prevention of different infections, including bacteremia, pneumonia, and sepsis. ]]>
	
	</description>
	<pubDate>
	Thu, 15 Oct 2009 14:45:36 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1013467.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1013433.do</link>
	<title>Endovascular repair of aortic aneurysm reduces short-term mortality</title>
	<description>
	
	   <![CDATA[ The OVER study of abdominal aortic aneurysm shows that endovascular grafting has a lower mortality rate at 30 days than traditional open surgery. ]]>
	
	</description>
	<pubDate>
	Thu, 15 Oct 2009 14:15:51 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1013433.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1013409.do</link>
	<title>Racial background woefully underreported in CV trials </title>
	<description>
	
	   <![CDATA[ Two-thirds of the 156 trials considered by the AHA in preparing a recent guideline failed to even record the ethnic backgrounds of participants, a new study has found. The researchers call for the reporting of race/ethnicity to be mandatory in all clinical trials, and they suggest medical journals should enforce this policy.  ]]>
	
	</description>
	<pubDate>
	Thu, 15 Oct 2009 13:15:10 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1013409.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1013221.do</link>
	<title>New COI disclosure form for all ICMJE journals</title>
	<description>
	
	   <![CDATA[ The International Committee of Medical Journal Editors has adopted a new uniform disclosure form for reporting conflicts of interest. ]]>
	
	</description>
	<pubDate>
	Wed, 14 Oct 2009 15:15:57 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1013221.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1013165.do</link>
	<title>Expert council focuses on left main PCI: Guideline changes suggested</title>
	<description>
	
	   <![CDATA[ The group argues that the data are substantive enough for left main PCI to be a class IIb indication or even a class IIa indication in selected patients without coexisting multivessel disease. In contrast, the current ACC/AHA guidelines make left main PCI a class III indication unless patients are ineligible for CABG surgery.  ]]>
	
	</description>
	<pubDate>
	Wed, 14 Oct 2009 14:45:22 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1013165.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1013007.do</link>
	<title>A fish tale with merit: Omega-3 PUFAs underrated for heart failure </title>
	<description>
	
	   <![CDATA[ Are the data not shouting loud enough, or is cardiology hard of herring? Omega-3 fatty acids may have only a modest treatment effect in heart failure, but they've performed swimmingly in randomized and observational studies considering how few new HF drugs have been reeled in lately.  ]]>
	
	</description>
	<pubDate>
	Wed, 14 Oct 2009 12:30:27 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1013007.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1012925.do</link>
	<title>Scripps starts routine genetic testing for clopidogrel responsiveness </title>
	<description>
	
	   <![CDATA[ Scripps Health has announced that it is now offering patients undergoing elective stenting a test for the gene variants associated with an inability to convert clopidogrel to its active metabolite so that antiplatelet therapy can be individualized. ]]>
	
	</description>
	<pubDate>
	Wed, 14 Oct 2009 11:00:05 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1012925.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1012577.do</link>
	<title>Hospital efficiency gauged by resource use vs outcomes </title>
	<description>
	
	   <![CDATA[ An analysis of Medicare data from heart-failure patients at six California hospitals challenges the notion advanced by some studies that hospital efficiency can be measured by looking back at resource use on behalf of patients who ultimately died.   ]]>
	
	</description>
	<pubDate>
	Tue, 13 Oct 2009 16:00:00 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1012577.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1012809.do</link>
	<title>Diuretics effective as second-line therapy for hypertension </title>
	<description>
	
	   <![CDATA[ Diuretics, especially hydrochlorothiazide, are as effective when given as second-line therapy for high blood pressure as they are when used as initial treatment, according to the first review to look at this issue.  ]]>
	
	</description>
	<pubDate>
	Tue, 13 Oct 2009 12:00:48 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1012809.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1012533.do</link>
	<title>Hopes build for natriuretic-peptide risk stratification before noncardiac surgery </title>
	<description>
	
	   <![CDATA[ Could a preoperative blood assay take the place of imaging studies or other more costly assessments of cardiovascular risk? A meta-analysis suggests yes. A massive randomized trial is looking into it now.   ]]>
	
	</description>
	<pubDate>
	Tue, 13 Oct 2009 10:00:10 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1012533.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1011519.do</link>
	<title>Genetic variant again linked with statin side effects</title>
	<description>
	
	   <![CDATA[ Carriers of the <i>SLCO1B1*5 </i>allele are at a twofold increased risk of mild statin-induced side effects, and the majority of these individuals had normal creatine-kinase levels. ]]>
	
	</description>
	<pubDate>
	Mon, 12 Oct 2009 17:00:00 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1011519.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1012375.do</link>
	<title>Glucocorticoids seen to double risk of atrial arrhythmias </title>
	<description>
	
	   <![CDATA[ In a case-control study from Denmark, the risk of atrial fibrillation or flutter was significantly increased with current but not previous use of glucocorticoids for chronic obstructive pulmonary disease, rheumatoid arthritis, and other conditions. ]]>
	
	</description>
	<pubDate>
	Mon, 12 Oct 2009 16:00:00 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1012375.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1012397.do</link>
	<title>Vernakalant converts AF to sinus rhythm postsurgery</title>
	<description>
	
	   <![CDATA[ The drug, however, is still not yet approved by the Food and Drug Administration. ]]>
	
	</description>
	<pubDate>
	Fri, 09 Oct 2009 17:15:03 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1012397.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1012275.do</link>
	<title>Target HbA1c levels still the subject of much debate, but tailored therapy should be the aim </title>
	<description>
	
	   <![CDATA[ Diabetologists are trying to tease out the best message to convey when it comes to target HbA<sub>1c</sub> levels for primary-care physicians and other nonspecialists who might be treating patients with type 2 diabetes.  ]]>
	
	</description>
	<pubDate>
	Fri, 09 Oct 2009 16:45:25 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1012275.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1012161.do</link>
	<title>High adherence to antihypertensive therapy lowers cardiovascular risk</title>
	<description>
	
	   <![CDATA[ Newly diagnosed hypertensive individuals who stuck to their antihypertensive therapy had a significantly lower risk of cardiovascular events than low adherers.  ]]>
	
	</description>
	<pubDate>
	Fri, 09 Oct 2009 13:30:36 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1012161.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1012133.do</link>
	<title>EULAR: CV risk management in inflammatory arthritis</title>
	<description>
	
	   <![CDATA[ The European League Against Rheumatism has issued 10 recommendations for cardiovascular risk management in patients with rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. ]]>
	
	</description>
	<pubDate>
	Fri, 09 Oct 2009 11:45:12 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1012133.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1012103.do</link>
	<title>FDA clears colesevelam for FH in kids</title>
	<description>
	
	   <![CDATA[ The FDA has approved an expanded indication for colesevelam tablets and a new powder for oral suspension as an adjunct to diet and exercise to reduce LDL-C levels in boys and postmenarchal girls aged 10 to 17 years with heterozygous familial hypercholesterolemia. ]]>
	
	</description>
	<pubDate>
	Fri, 09 Oct 2009 11:00:39 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1012103.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1012007.do</link>
	<title>Coronary thrombosis—the culprit is not just plaque rupture </title>
	<description>
	
	   <![CDATA[ Clots derived from a different source&#151;erosions of the arterial wall&#151;may be an important cause of MI and sudden death, particularly in younger women, who may need a different approach to treatment, new research suggests.  ]]>
	
	</description>
	<pubDate>
	Thu, 08 Oct 2009 17:45:48 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1012007.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1011961.do</link>
	<title>New joint statement streamlines definition of metabolic syndrome</title>
	<description>
	
	   <![CDATA[ The statement from the International Diabetes Federation, the National Heart, Lung, and Blood Institute, and the American Heart Association, among others, formalizes the definition of the metabolic disorder with the hope of eliminating some of the confusion regarding how to identify patients with the syndrome. ]]>
	
	</description>
	<pubDate>
	Thu, 08 Oct 2009 16:45:46 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1011961.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1011883.do</link>
	<title>New review confirms homocysteine lowering does not prevent CVD events</title>
	<description>
	
	   <![CDATA[ The latest review to look at the effects of homocysteine lowering with vitamin-B supplementation has come to much the same conclusions as most other studies and analyses in this field.  ]]>
	
	</description>
	<pubDate>
	Thu, 08 Oct 2009 15:30:45 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1011883.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1011331.do</link>
	<title>Experts debate bariatric surgery as a cure for diabetes </title>
	<description>
	
	   <![CDATA[ Under the some-say-misguided term "metabolic" surgery, gastric bypass is now being used in some instances to treat diabetics who are not considered morbidly obese. Experts say the mostly circumstantial evidence on this is intriguing, but prospective data are desperately needed in this group of patients. ]]>
	
	</description>
	<pubDate>
	Thu, 08 Oct 2009 13:15:54 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1011331.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1011187.do</link>
	<title>IRIS confirms: No survival gains from early post-MI primary-prevention ICDs</title>
	<description>
	
	   <![CDATA[ Defibrillators implanted within a month of acute MI may prevent sudden cardiac deaths, but they don't reduce overall mortality, according to a trial that supports current guidelines based primarily on the smaller 2004 trial DINAMIT.   ]]>
	
	</description>
	<pubDate>
	Wed, 07 Oct 2009 17:00:00 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1011187.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1011211.do</link>
	<title>Elizabeth Taylor tweets about experimental MitraClip procedure </title>
	<description>
	
	   <![CDATA[ The MitraClip will likely go before the FDA early next year, meaning that Taylor's experience with the device will form a small (and anonymous) part of the FDA's deliberations. ]]>
	
	</description>
	<pubDate>
	Wed, 07 Oct 2009 16:00:04 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1011211.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1010925.do</link>
	<title>Lupus anticoagulant a major risk factor for stroke and MI in young women</title>
	<description>
	
	   <![CDATA[ Results of the RATIO study suggest lupus anticoagulant, but not anticardiolipin or antiprothrombin antibodies, is associated with increased stroke risk and to a lesser extent MI.  ]]>
	
	</description>
	<pubDate>
	Wed, 07 Oct 2009 10:00:40 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1010925.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1010897.do</link>
	<title>Mercury/blood-pressure link should guide fish choices </title>
	<description>
	
	   <![CDATA[ An association seen between mercury levels and blood pressure, even after considering omega-3s and selenium, has researchers warning about the need to weigh the risks and benefits of fish consumption and to steer clear of bigger predators.  ]]>
	
	</description>
	<pubDate>
	Tue, 06 Oct 2009 16:45:03 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1010897.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1010873.do</link>
	<title>Counseling and education fail to reduce prehospital delays in ACS</title>
	<description>
	
	   <![CDATA[ Even among patients with documented ischemic heart disease, an intensive program of education and counseling about the importance of seeking treatment quickly does not lead to reductions in prehospital delays or increased ambulance use among those experiencing the signs and symptoms of an ACS, a new study shows. ]]>
	
	</description>
	<pubDate>
	Tue, 06 Oct 2009 16:00:00 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1010873.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1010849.do</link>
	<title>Incidental findings on cardiac CT costly and rarely clinically significant</title>
	<description>
	
	   <![CDATA[ Among nearly 1000 consecutive patients who underwent cardiac CT, 41% had noncardiac incidental findings, but just 1.2% of these were clinically significant. While another 7% were "indeterminate," none of these inconclusive findings became clinically significant during follow-up. ]]>
	
	</description>
	<pubDate>
	Tue, 06 Oct 2009 15:15:01 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1010849.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1010825.do</link>
	<title>China death toll due to hypertension worse than predicted </title>
	<description>
	
	   <![CDATA[ The first prospective study using real data to inform the number of people suffering from and dying due to high blood pressure in China finds the problem is much worse than previously thought. A number of initiatives are planned to try to tackle this crisis. ]]>
	
	</description>
	<pubDate>
	Tue, 06 Oct 2009 14:15:24 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1010825.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1010799.do</link>
	<title>Thiazolidinediones once again linked to fracture risk</title>
	<description>
	
	   <![CDATA[ Risk appeared to be similar in men and women, with exposure to either rosiglitazone or pioglitazone, and across a range of fracture sites. The longer the duration of exposure to the drugs, the greater the risk.  ]]>
	
	</description>
	<pubDate>
	Tue, 06 Oct 2009 12:30:18 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1010799.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1010721.do</link>
	<title>Simple, fixed-dose drug bundle may lower MI and stroke risk</title>
	<description>
	
	   <![CDATA[ A bundle of medium doses of a statin and an ACE inhibitor appears to lower CV risk in high-risk individuals, an observational study suggests, but critics caution that these are early days.  ]]>
	
	</description>
	<pubDate>
	Tue, 06 Oct 2009 10:15:41 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1010721.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1010685.do</link>
	<title>Acute heart-failure prediction model blends clinical gestalt with natriuretic peptides</title>
	<description>
	
	   <![CDATA[ Its developers say the prediction model for guiding management of patients presenting with dyspnea can make a difference when clinicians aren't sure about the diagnosis based on clinical signs. An editorial takes issue.   ]]>
	
	</description>
	<pubDate>
	Mon, 05 Oct 2009 17:00:00 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1010685.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1010661.do</link>
	<title>20 000-patient DAPT clinical trial starts enrolling with eight industry sponsors on board </title>
	<description>
	
	   <![CDATA[ The trial, rumored to cost more than $100 million, is a first for collaboration: eight drug and device companies are backing the trial, along with the FDA. The study is powered to detect a difference in stent thrombosis and major adverse events between patients taking 12 or 30 months of aspirin plus clopidogrel or prasugrel. ]]>
	
	</description>
	<pubDate>
	Mon, 05 Oct 2009 16:45:09 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1010661.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1010617.do</link>
	<title>Philips recalls thousands of AEDs  </title>
	<description>
	
	   <![CDATA[ The automatic external defibrillators were distributed by Philips Medical and Laerdal Medical with model numbers M3860A, M3861A, M3840A, and M3841A.   ]]>
	
	</description>
	<pubDate>
	Mon, 05 Oct 2009 14:00:59 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1010617.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1010567.do</link>
	<title>Hypoglycemia associated with increased risk of MI among US veterans with diabetes </title>
	<description>
	
	   <![CDATA[ Close attention should be paid to diabetes patients who experience an episode of hypoglycemia, because a new case-control study suggests a 65% increased risk of MI in the immediate two-week aftermath of such an event. Doctors should tailor diabetes therapies to minimize the risk of hypoglycemia occurring, say the researchers.  ]]>
	
	</description>
	<pubDate>
	Mon, 05 Oct 2009 13:45:19 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1010567.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1010343.do</link>
	<title>Next up: Drug-eluting stents for erectile dysfunction </title>
	<description>
	
	   <![CDATA[ In what may be the first clinical trial to test a DES in the pudendal artery, investigators at nine sites are looking at whether pudendal stenting is safe and effective in men who have failed PDE-5 inhibitors.  ]]>
	
	</description>
	<pubDate>
	Fri, 02 Oct 2009 17:45:26 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1010343.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1010307.do</link>
	<title>Stroke reduction with dronedarone shown in post hoc analysis</title>
	<description>
	
	   <![CDATA[ Investigators say that although the analysis raises the possibility that a drug with antiarrhythmic activity could reduce the risk of stroke, dronedarone is not a replacement for oral anticoagulant therapy or a treatment for stroke prevention. ]]>
	
	</description>
	<pubDate>
	Fri, 02 Oct 2009 17:15:19 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1010307.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1010255.do</link>
	<title>Insulin glargine and cancer: Association, no causal link </title>
	<description>
	
	   <![CDATA[ That was the conclusion of a recent panel of experts, perhaps alleviating concerns raised by several recent studies.   ]]>
	
	</description>
	<pubDate>
	Fri, 02 Oct 2009 15:00:18 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1010255.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1010173.do</link>
	<title>New heparin standards reduce potency of drug 10%</title>
	<description>
	
	   <![CDATA[ The Food and Drug Administration is asking clinicians to be aware of the change, particularly in settings where an immediate anticoagulant effect is clinically important. ]]>
	
	</description>
	<pubDate>
	Fri, 02 Oct 2009 12:30:34 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1010173.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1010093.do</link>
	<title>New &quot;principles&quot; on authorship and COI from PhRMA get mixed response</title>
	<description>
	
	   <![CDATA[  The "Principles on Conduct of Clinical Trials and Communication of Clinical Trial Results" echo recent standards set by medical journal editors, but some observers say the document, which has no penalty component, lacks real teeth. ]]>
	
	</description>
	<pubDate>
	Fri, 02 Oct 2009 12:00:10 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1010093.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1009961.do</link>
	<title>Wealthy Americans more likely to benefit from statin therapy than poor</title>
	<description>
	
	   <![CDATA[ In the past 30 years, wealthier Americans, who were once more likely to have high total- and LDL-cholesterol levels than poorer individuals, now have a significantly better lipid profile. Statins, say researchers, may have contributed to the expanding social disparities in cardiovascular risk.  ]]>
	
	</description>
	<pubDate>
	Thu, 01 Oct 2009 16:45:51 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1009961.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1009907.do</link>
	<title>HORIZONS analysis: 600-mg clopidogrel load preferable in primary PCI</title>
	<description>
	
	   <![CDATA[ The higher dose was associated with a reduced rate of ischemic events without an increase in bleeding in patients with STEMI undergoing primary PCI. ]]>
	
	</description>
	<pubDate>
	Thu, 01 Oct 2009 16:00:46 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1009907.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1009753.do</link>
	<title>REVERSE, MADIT-CRT make case for extending CRT to mild heart failure: Should guidelines change?</title>
	<description>
	
	   <![CDATA[ Now in print after having been presented at meetings, the REVERSE randomized trial's European-cohort two-year results are consistent with the recently published, much larger MADIT-CRT trial in showing both clinical and LV structural benefits from resynchronization therapy in patients with NYHA class 1-2 heart failure. ]]>
	
	</description>
	<pubDate>
	Thu, 01 Oct 2009 10:30:49 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1009753.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1009621.do</link>
	<title>Time to act: Cardiologists, diabetes docs, and psychiatrists urged to work together to tackle CVD in the mentally ill </title>
	<description>
	
	   <![CDATA[ Doctors from across the specialties of cardiology, diabetes, and psychiatry are being urged to collaborate to improve care for the mentally ill, who are more likely to die from cardiovascular disease than any other cause. ]]>
	
	</description>
	<pubDate>
	Wed, 30 Sep 2009 14:00:04 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1009621.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1009465.do</link>
	<title>Pump may not be the culprit in &quot;pump head&quot; after CABG</title>
	<description>
	
	   <![CDATA[ The decline in cognitive function that is often seen after CABG may not be related to the use of cardiopulmonary bypass or to embolic debris in the bloodstream from the bypass pump, Chinese researchers say. ]]>
	
	</description>
	<pubDate>
	Wed, 30 Sep 2009 11:15:57 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1009465.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1009413.do</link>
	<title>Only one in eight strokes heralded by TIA</title>
	<description>
	
	   <![CDATA[ A new study finds only about one in eight strokes are preceded by transient ischemic attack. The results underline the need for a broader approach to primary prevention, researchers say.   ]]>
	
	</description>
	<pubDate>
	Wed, 30 Sep 2009 10:00:41 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1009413.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1009297.do</link>
	<title>Kissing-balloon dilatation of side branch not needed with one-stent bifurcation approach</title>
	<description>
	
	   <![CDATA[ With the one-stent technique for the treatment of bifurcation lesions, the use of routine kissing-balloon dilatation of the side branch does not improve six-month clinical outcomes. ]]>
	
	</description>
	<pubDate>
	Tue, 29 Sep 2009 16:15:30 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1009297.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1009135.do</link>
	<title>Doctor-led &quot;hospital-at-home&quot; care subs for hospitalization in acute heart failure</title>
	<description>
	
	   <![CDATA[ They lived just as long, but in a small randomized trial, patients with acute decompensated heart failure who received hospital-quality care in their homes as an alternative to hospital admission after presentation to the emergency department benefited in ways missed by those managed as inpatients in the traditional manner.  ]]>
	
	</description>
	<pubDate>
	Tue, 29 Sep 2009 12:00:05 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1009135.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1009035.do</link>
	<title>BCIS-1 trial: &quot;Bailout&quot; intra-aortic balloon pump beats elective use in low EF/high-risk patients</title>
	<description>
	
	   <![CDATA[ The study provides an important answer to a question that has divided some interventionalists. Those who "swear" by IABP use for all high-risk, low-EF patients should rethink their practice. In hypotensive patients and those with cardiogenic shock, IABPs play a key role.  ]]>
	
	</description>
	<pubDate>
	Tue, 29 Sep 2009 10:45:47 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1009035.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1008965.do</link>
	<title>FAUST: Ultrasound guidance improves femoral access in cases of high bifurcation, reduces risk of complication</title>
	<description>
	
	   <![CDATA[ <b><i>CORRECTED </i></b><i>// </i>A study has found that although ultrasound imaging doesn't seem to improve upon the overall success rate of fluoroscopy-assisted femoral-access PCI, it does seem to facilitate the procedure, reducing the risk of access complications by 59% and doubling the first-pass success rate. ]]>
	
	</description>
	<pubDate>
	Tue, 29 Sep 2009 09:45:25 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1008965.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1008859.do</link>
	<title>Diabetes: An independent risk factor for AF </title>
	<description>
	
	   <![CDATA[ Atrial fibrillation was more likely to develop in diabetics than in nondiabetics in a new observational study, and the link was particularly strong in women.  ]]>
	
	</description>
	<pubDate>
	Tue, 29 Sep 2009 00:00:23 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1008859.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1008905.do</link>
	<title>Early statin therapy in ACS: What&#39;s the level of evidence?</title>
	<description>
	
	   <![CDATA[ The use of high-dose statin therapy early in the course of acute coronary syndrome currently has the highest possible (class IA) recommendation in US guidelines, but a group of experts argues that this is inaccurate based on current evidence. However, they stress, they are not saying statins should not be used in this indication. ]]>
	
	</description>
	<pubDate>
	Mon, 28 Sep 2009 17:00:00 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1008905.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1008719.do</link>
	<title>New biomarker, galectin-3, shows risk-stratification potential in chronic heart failure </title>
	<description>
	
	   <![CDATA[ The proposed biomarker, which seems to apparently play a role in the progression of cardiomyopathy and heart failure, predicted mortality or HF hospitalization in a post hoc analysis from the already published COACH randomized trial. ]]>
	
	</description>
	<pubDate>
	Mon, 28 Sep 2009 15:00:18 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1008719.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1008623.do</link>
	<title>CHARISMA Genomics Substudy links loss-of-function allele and bleeding</title>
	<description>
	
	   <![CDATA[ Patients who are homozygous for the CYP2C19*2 allele are at increased risk of ischemia but less likely to bleed. Routine genotyping for the variant still isn't recommended. ]]>
	
	</description>
	<pubDate>
	Mon, 28 Sep 2009 14:15:11 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1008623.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1008447.do</link>
	<title>Sitagliptin linked to acute pancreatitis, FDA warns</title>
	<description>
	
	   <![CDATA[ The FDA is revising prescribing information for sitagliptin and sitagliptin/metformin after cases of acute pancreatitis, some severe, surfaced in postmarketing reports. ]]>
	
	</description>
	<pubDate>
	Mon, 28 Sep 2009 13:00:51 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1008447.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1008381.do</link>
	<title>Skin lesions from heparin more common than thought </title>
	<description>
	
	   <![CDATA[ A new prospective study has found the incidence of heparin-induced skin lesions to be around 7.5%. Women, the obese, and those on heparin therapy for longest are most at risk.  ]]>
	
	</description>
	<pubDate>
	Mon, 28 Sep 2009 12:00:00 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1008381.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1008283.do</link>
	<title>No relationship between significant carotid stenosis and stroke after cardiac surgery</title>
	<description>
	
	   <![CDATA[ A large single-center retrospective study finds no association between carotid stenosis and stroke after cardiac surgery. The findings may finally answer the question of whether carotid endarterectomy prior to or during heart surgery provides any benefit.  ]]>
	
	</description>
	<pubDate>
	Mon, 28 Sep 2009 10:00:08 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1008283.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1008155.do</link>
	<title>Reduced bleeding and comparable stent thrombosis with DES and bare-metal stents: HORIZONS-AMI at two years</title>
	<description>
	
	   <![CDATA[ Two-year data showed significant reductions in bleeding and cardiac mortality in patients treated with bivalirudin when compared with those treated with heparin plus a GP IIb/IIIa inhibitor. In the stent arm of the trial, researchers showed that stent thrombosis rates were equivalent between DES and bare-metal stents, although both rates were high, at 4.1%.  ]]>
	
	</description>
	<pubDate>
	Fri, 25 Sep 2009 17:55:17 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1008155.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1008053.do</link>
	<title>PLATO-Invasive: Impressive ticagrelor results mirror overall trial findings </title>
	<description>
	
	   <![CDATA[ The prespecified subset analysis helps clarify the performance of the drug in patients managed invasively, including adding new insights into its benefits over both the 300-mg and 600-mg loading doses of clopidogrel.  ]]>
	
	</description>
	<pubDate>
	Fri, 25 Sep 2009 17:30:21 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1008053.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1007977.do</link>
	<title>Hormonal therapies for prostate cancer increase risk of heart disease  </title>
	<description>
	
	   <![CDATA[ A huge study of Swedish data shows an increased risk of all types of cardiovascular disease in men taking hormonal therapies for prostate cancer.  ]]>
	
	</description>
	<pubDate>
	Fri, 25 Sep 2009 16:30:12 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1007977.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1007873.do</link>
	<title>PROSPECT: Vulnerable lesions lead to unstable angina rather than MI or death</title>
	<description>
	
	   <![CDATA[ After successful PCI, 20% of patients go on to have a MACE at three years and 12% of patients develop events from nonculprit lesions. PROSPECT investigators say, however, that events from these nonculprit lesions are more likely to be unstable angina or progressive angina, rather than harder events such as MI or cardiac death. ]]>
	
	</description>
	<pubDate>
	Fri, 25 Sep 2009 14:15:11 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1007873.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1007609.do</link>
	<title>Tributes to Helmut Drexler, who has died at age 58</title>
	<description>
	
	   <![CDATA[ Dr Helmut Drexler, who suffered a sudden cardiac death earlier this month, was at the height of his career and will be sorely missed, friends told <b>heart</b><b><i>wire</i></b>.  ]]>
	
	</description>
	<pubDate>
	Fri, 25 Sep 2009 11:45:46 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1007609.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1007461.do</link>
	<title>BNP-boosting gene variant hints at possible screening, cardioprotective roles  </title>
	<description>
	
	   <![CDATA[ A single-nucleotide polymorphism associated with chronically raised natriuretic-peptide levels is common enough to potentially influence interpretation of BNP and NT-proBNP assays under some circumstances, researchers say; there is increasing evidence that the gene variant may enhance survival in some patient groups. ]]>
	
	</description>
	<pubDate>
	Fri, 25 Sep 2009 10:45:02 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1007461.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1007305.do</link>
	<title>COMPARE: &quot;Real-world&quot; randomized trial favors Xience V over Taxus Liberté </title>
	<description>
	
	   <![CDATA[ COMPARE is the second of two large randomized controlled trials comparing a Taxus stent with Xience V to show a clear benefit of the newer stent. ]]>
	
	</description>
	<pubDate>
	Fri, 25 Sep 2009 08:30:19 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1007305.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1007269.do</link>
	<title>Doubling dose of clopidogrel benefits STEMI patients without risk of bleeding</title>
	<description>
	
	   <![CDATA[ Doubling the dose of clopidogrel reduced the risk of MI and stent thrombosis in STEMI patients without increasing the risk of bleeding. The benefit extended to patients who received a bare-metal stent or a drug-eluting stent. ]]>
	
	</description>
	<pubDate>
	Thu, 24 Sep 2009 17:45:49 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1007269.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1007145.do</link>
	<title>COGENT: No CV events but significant GI benefits of PPI omeprazole</title>
	<description>
	
	   <![CDATA[ The randomized controlled trial results should put a stop to alarmist headlines about PPIs blunting efficacy of antiplatelet drugs, experts say. By withholding PPIs, physicians are doing more harm than good, the results suggest. ]]>
	
	</description>
	<pubDate>
	Thu, 24 Sep 2009 16:30:07 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1007145.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1007049.do</link>
	<title>FAME lives on: FFR results durable at two years</title>
	<description>
	
	   <![CDATA[ The past few cardiology meetings have included data on the FAME study, and TCT 2009 was no exception. Investigators showed that the one-year and 18-month results were durable out to two years, although some researchers would like to see the study replicated to conclusively prove the added value of fractional flow reserve testing. ]]>
	
	</description>
	<pubDate>
	Thu, 24 Sep 2009 14:45:38 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1007049.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1006911.do</link>
	<title>New Canadian lipid guidelines will recommend CRP testing for certain patients </title>
	<description>
	
	   <![CDATA[ New Canadian guidelines for the diagnosis and treatment of dyslipidemia and the prevention of cardiovascular disease will recommend the testing of hs-CRP for certain patients, most notably those at intermediate risk. However, the lead author stresses that the majority of patients will not require a CRP test and that recommending and promoting a healthy lifestyle must be the first port-of-call for doctors.  ]]>
	
	</description>
	<pubDate>
	Thu, 24 Sep 2009 13:45:07 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1006911.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1006629.do</link>
	<title>SIRTAX LATE: No differences in MACE for first-generation stents at five years</title>
	<description>
	
	   <![CDATA[ After one year, Cypher had lower rates of death, MI, or repeat PCIs than Taxus in the SIRTAX trial. But four years later, investigators say all differences between the two have disappeared, in part due to more late "catch-up" with the Cypher.  ]]>
	
	</description>
	<pubDate>
	Thu, 24 Sep 2009 08:30:17 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1006629.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1006595.do</link>
	<title>Stent sandwich: First-generation stents equal for Cypher in-stent restenosis</title>
	<description>
	
	   <![CDATA[ Late lumen loss at one year, the primary end point, was equivalent between the Cypher and Taxus stent at one year among patients with restenosis after initial treatment with the Cypher stent.  ]]>
	
	</description>
	<pubDate>
	Thu, 24 Sep 2009 07:45:13 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1006595.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1006453.do</link>
	<title>SPIRIT IV: Xience V trumps Taxus for clinically driven end points, although diabetic questions linger</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED</i></b> // Rates of target lesion failure were significantly lower for the everolimus-eluting Xience V stent for the trial as a whole. In diabetic patients only, however, no differences were seen between the two stents. ]]>
	
	</description>
	<pubDate>
	Wed, 23 Sep 2009 16:15:24 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1006453.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1006177.do</link>
	<title>Should patients go directly to a PCI-capable hospital? Two studies, different results</title>
	<description>
	
	   <![CDATA[ One trial showed that despite a mean treatment delay of 67 minutes, STEMI patients undergoing primary PCI taken first to an emergency department before transfer had equivalent rates of major adverse cardiac events when compared with those who presented directly to a PCI facility. A smaller study showed that taking patients directly to the cardiac center resulted in significantly better survival when compared with patients who were transported to an emergency department. ]]>
	
	</description>
	<pubDate>
	Wed, 23 Sep 2009 10:45:51 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1006177.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1006131.do</link>
	<title>Changing PARTNER: Program tweaks overshadow updates from transcatheter-valve studies</title>
	<description>
	
	   <![CDATA[ A packed session of interventionalists eager to hear more about long-term safety and efficacy were caught off-guard by news that a new co-primary end point has been added to cohort B.  ]]>
	
	</description>
	<pubDate>
	Wed, 23 Sep 2009 09:15:00 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1006131.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1006071.do</link>
	<title>Senators question Dr Martin Leon&#39;s financial links to industry</title>
	<description>
	
	   <![CDATA[ <b><i>UPDATED</i></b> // The letter, from Sens Herb Kohl and Charles Grassley, states that Leon did not fully disclose much of the money he has received from outside companies.  ]]>
	
	</description>
	<pubDate>
	Tue, 22 Sep 2009 17:15:30 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1006071.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1006021.do</link>
	<title>Enoxaparin cheaper than UFH in STEMI patients undergoing thrombolysis? </title>
	<description>
	
	   <![CDATA[ A new analysis of the EXTRACT-TIMI 25 trial concludes that enoxaparin is slightly cheaper in the long term than unfractionated heparin for STEMI patients undergoing thrombolysis. But there are questions as to why 30-day data and not one-year results were used to model long-term cost-effectiveness.  ]]>
	
	</description>
	<pubDate>
	Tue, 22 Sep 2009 17:15:18 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1006021.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1005959.do</link>
	<title>FDA approves aliskiren/valsartan combo for HTN</title>
	<description>
	
	   <![CDATA[  ]]>
	
	</description>
	<pubDate>
	Tue, 22 Sep 2009 15:15:54 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1005959.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1005711.do</link>
	<title>Mixed start to planned MARVEL trial of post-MI autologous skeletal-myoblast therapy</title>
	<description>
	
	   <![CDATA[ A pilot analysis suggests the cell therapy can improve functional capacity, but amiodarone may be needed to prevent ventricular arrhythmias; its investigators say they plan to switch gears on the remainder of the study. ]]>
	
	</description>
	<pubDate>
	Tue, 22 Sep 2009 14:00:42 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1005711.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1005755.do</link>
	<title>Should left main PCI be a class IIa indication?</title>
	<description>
	
	   <![CDATA[ TCT 2009 kicked off with a discussion on revascularization strategies for left main PCI. Interventionalist Dr Paul Teirstein argues the data are sufficient for left main PCI to be a class IIa indication, upgrading it from the current class III recommendation, but surgeon Dr David Taggart says that CABG is still the preferred revascularization option in the majority of left main patients. ]]>
	
	</description>
	<pubDate>
	Tue, 22 Sep 2009 13:15:44 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1005755.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1005627.do</link>
	<title>Three-year SPIRIT III results show enduring edge for Xience V over Taxus </title>
	<description>
	
	   <![CDATA[ Three-year target vessel failure remained statistically lower for the everolimus-eluting Xience V stent (which is also marketed as the Promus) than for the paclitaxel-eluting Taxus stent.  ]]>
	
	</description>
	<pubDate>
	Tue, 22 Sep 2009 11:45:00 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1005627.do</guid>
	</item>


	<item>
	<link>http://test.theheart.org/article/1005381.do</link>
	<title>ENDEAVOR IV: Revascularization rates similar for Endeavor and Taxus at three years, with Endeavor &quot;pulling ahead&quot; for safety </title>
	<description>
	
	   <![CDATA[ Rates of cardiac death and MI actually statistically favor the Endeavor stent at three years, new data show. Stent thrombosis occurred just once after one year for Endeavor, as compared with 11 cases after the one-year mark in the Taxus-treated patients. ]]>
	
	</description>
	<pubDate>
	Tue, 22 Sep 2009 09:45:47 EDT
	</pubDate>
	<guid>http://test.theheart.org/article/1005381.do</guid>
	</item>

</channel>
</rss>

